Clinical characteristics of patients assessed by IC
. | No. . | % . |
|---|---|---|
| Total | 42 | 100 |
| Mean age, y (range) | 61 (35-86) | NA |
| Female | 12 | 28.5 |
| M component | ||
| IgG | 36 | 85.7 |
| IgA | 4 | 9.5 |
| Light chain | 2 | 4.8 |
| Nonsecretory | 0 | 0 |
| K | 33 | 78.5 |
| Salmon and Durie stage | ||
| I | 14 | 33.3 |
| II-III | 28 | 66.7 |
| Extramedullary disease | 5 | 12.0 |
. | No. . | % . |
|---|---|---|
| Total | 42 | 100 |
| Mean age, y (range) | 61 (35-86) | NA |
| Female | 12 | 28.5 |
| M component | ||
| IgG | 36 | 85.7 |
| IgA | 4 | 9.5 |
| Light chain | 2 | 4.8 |
| Nonsecretory | 0 | 0 |
| K | 33 | 78.5 |
| Salmon and Durie stage | ||
| I | 14 | 33.3 |
| II-III | 28 | 66.7 |
| Extramedullary disease | 5 | 12.0 |
IC indicates immunohistochemistry; NA, not applicable.